HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,561-1,572 of 1,811
Behavioral study icon
CompletedNCT06567444

Computerized Working Memory Training

Official study title

Improving Cognitive Function in Chinese Children With ADHD and/or RD Through Computerized Working Memory Training

This study has finished and is no longer accepting participants.

In Tai Po
ADHDInterventional studyAges 6–11
Countries
China
Sponsor
Education University of Hong Kong
Drug study icon
CompletedNCT04138498

CTx-1301 Comparative Bioavailability Study

Official study title

A Randomized, Single-dose, Four-sequence, Four-period, Crossover Study in Adult ADHD Subjects to Establish Safety, Tolerability, and Comparative Bioavailability of CTx-1301 (Dexmethylphenidate) to Focalin XR™ Under Fasted Conditions

This study has finished and is no longer accepting participants.

In Overland Park
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Cingulate Therapeutics
Other study type icon
CompletedNCT04095377

Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.

Official study title

Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019 - A Retrospective Study

This study has finished and is no longer accepting participants.

In Rishon LeZiyyon
ADHDObservational studyAges 18+
Countries
Israel
Sponsor
QuantalX Neuroscience
Drug study icon
CompletedNCT00190736

Once-Daily Atomoxetine Hydrochloride for ADHD

What is this study about?

This study evaluated the safety and effectiveness of Atomoxetine Hydrochloride for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Lafayette
ADHDMedication studyAges 18–54
Countries
United States
Sponsor
Eli Lilly and Company
Drug study icon
Active Not RecruitingNCT04219280

Evaluating Treatment of ADHD in Children With Down Syndrome

Official study title

Evaluating Assessment and Medication Treatment of ADHD in Children With Down Syndrome

This study is no longer accepting new participants.

Multiple locations, including Sacramento
ADHDMedication studyAges 6–17
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Behavioral study icon
WithdrawnNCT04864808

Helping Toddlers and Parents Together

Official study title

Treating ADHD Parents and Their Infants Via Telehealth: Developing an Early Parenting Intervention Using a Deployment-focused Intervention Design

This study was withdrawn before enrollment.

In Washington D.C.
ADHDBehavioural studyAges 12 months–55 years
Countries
United States
Sponsor
University of Maryland, College Park
Behavioral study icon
CompletedNCT04188626

Identification of Biomarkers to Predict Driver Take-over Control Quality

Official study title

Identification of Physiological and Behavioural Biomarkers to Predict Take-over Control Quality in Level 3 Conditionally Automated Vehicles

This study has finished and is no longer accepting participants.

In Bordeaux
ADHDBehavioural studyAges 20–75
Countries
France
Sponsor
PSA Automobiles S.A.
Other study type icon
CompletedNCT04144790

Impact of Iron Supplementation Treatment on Brain Iron Concentrations

Official study title

Impact of Iron Supplementation Treatment on Brain Iron Concentrations Among Children With ADHD & Restless Leg Syndrome Combined With Periodic Limb Movements in Sleep

This study has finished and is no longer accepting participants.

In Baltimore
ADHDObservational studyAges 5–18
Countries
United States
Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Drug study icon
WithdrawnNCT01844427

Memantine Monotherapy for Executive Dysfunction and ADHD

Official study title

Memantine Monotherapy for Executive Dysfunction and ADHD: A Pilot Study

This study was withdrawn before enrollment.

Location not clearly listed
ADHDMedication studyAges 18–45
Countries
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.